Protection and Performance with PremiumCoat®
Contact Aptar Pharma’s expert team today to learn more about how PremiumCoat® can accelerate and derisk your drug development program.
Publications, Pharmaceutical
Aptar Pharma Reviews the Importance of Silicone Levels on Vial Stoppers
16 May 2022
When developing new injectable drugs, manufacturers must consider the importance of primary packaging to ensure the drug is protected from the initial filling process to being administered to a patient. Silicone is added to every elastomeric closure component and is essential to ensure the products perform well on filling lines and in conjunction with the glass container. The PremiumCoat® platform of vial stoppers, pre-filled syringe plungers and services combine a state-of-the-art Bromobutyl formulation with a market proven ETFE film that help limit the transfer of extractables and leachables into the drug formulation.
By: Sébastien Cordier (Aptar Pharma) Estelle Verger (Aptar Pharma) Vincent Holterboch
16 May 2022
In this article, Aptar Pharma uses inductively coupled plasma optical emission spectrometry (ICP-OES) to demonstrate that our proprietary manufacturing process optimizes the distribution of silicone oil on our PremiumCoat®. By limiting the quantity of silicone that comes in contact with the drug product, PremiumCoat® derisks the development of sensitive drugs.
